Skip to content
varsome_insights-1
Know Where Your Variant Is Being Seen - Before Feasibility Begins.
VarSome Insights connects your biomarker programme with real-world clinician search activity, giving clinical development and medical affairs teams the data they need for faster site selection, smarter investigator outreach, and a clearer picture of disease prevalence — before committing feasibility spend.
Insights landing graphic
What Insights?
clinicians Insights Landing Images

Investigator Identification

Identify which investigators are actively searching your variants, how they are classifying them, and which institutions they represent.
GeoPrev1 Insights Landing Images

Prevalence Mapping

Use real-world search activity to map where cases are likely being seen today, supplementing or challenging published prevalence estimates.
trends Insights Landing Images

Early Case Detection

Track search volume and classification trends over time. Spot rising case activity in new geographies early to inform recruitment and strategy.
Outreach Insights Landing Images

Investigator Outreach

Connect with investigators who have searched for your variants and consented to be contacted. Place native ads on VarSome gene and variant pages.
Why VarSome?

VarSome.com attracts tens of thousands of page views per month from healthcare professionals across six continents. With Insights, you can place your message directly in front of the clinicians and researchers already engaging with your variants of interest, ensuring visibility where it matters most.

Use real-world search activity to track disease prevalence and identify where patients are most likely to be found. VarSome Insights helps you pinpoint candidate sites and connect with clinicians working in those regions, streamlining recruitment and supporting smarter trial planning.

Join the world’s largest network of clinical geneticists and healthcare professionals. VarSome Insights lets you tap into live data from this global community, helping you collaborate, share knowledge, and strengthen clinical programmes with insights gathered across more than 150 countries.

Over 87% of VarSome users have consented to be contacted for relevant trials and therapies. With VarSome Insights, you can reach out directly to clinicians who have shown interest in your variants, opening a dialogue that leads to faster engagement and stronger partnerships.

Insights go beyond reporting. Whether it’s contacting clinicians who have searched for your variants or placing targeted messages on VarSome result pages, you can translate data into meaningful engagement that accelerates clinical development.

VarSome Insights provides both retrospective and real-time reporting on your variants of interest. Retrospective reports look back up to two years, revealing historical search patterns and past clinical interest. Active weekly reports keep you up to date with current activity, highlighting where new searches are happening and where patients may be emerging. Together, these reports give you the historical context and real-time perspective needed to support recruitment, site selection, and clinician outreach.

Prevalence Inferance Use Case

ASAH1 Prevalence from Real-World Search Data

Using VarSome Insights, researchers at Aceragen and Saphetor analyzed two years of ASAH1 gene queries to infer that ASAH1-related diseases are more prevalent than previously reported - identifying case activity in regions that had not appeared in traditional prevalence studies.

The methodology is replicable for any programme built around a defined variant or gene. For rare diseases where published prevalence data is sparse or unreliable, search volume from a global clinical community can provide an independent, real-world signal to inform early development decisions.

See The Poster
aceragen poster
What Do Our Partners Say?

Successful Clinical Trial Enrolment
"We had another person agree to participate in our clinical trial.
That's a great record of success."

Disease Prevalence Mapping
"Traditional prevalence efforts are usually a costly and timely endeavor.
Inferred prevalence may circumvent this spend during early
development efforts."

Rare Disease Awareness
"We look forward to leveraging Saphetor's innovative approach
to bring together the global genomics community to build awareness
in our rare disease program."

Find Out Where Your Variants Are Being Seen